Pain Therapeutics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
41,119.00
-
-
-
-
Cost of Goods Sold (COGS) incl. D&A
-
15.00
45.00
58.00
68.00
Gross Income
-
15.00
45.00
58.00
68.00
SG&A Expense
9,754.00
12,418.00
14,157.00
14,899.00
11,881.00
EBIT
31,365.00
12,433.00
14,202.00
14,957.00
11,949.00
Pretax Income
31,471.00
12,386.00
14,145.00
14,850.00
11,911.00
Consolidated Net Income
31,544.00
12,386.00
14,145.00
14,850.00
11,911.00
Net Income
31,544.00
12,386.00
14,145.00
14,850.00
11,911.00
Net Income After Extraordinaries
31,544.00
12,386.00
14,145.00
14,850.00
11,911.00
Net Income Available to Common
31,544.00
12,386.00
14,145.00
14,850.00
11,911.00
EPS (Basic)
4.88
1.89
2.17
2.31
1.82
Basic Shares Outstanding
6,429.60
6,467.00
6,536.60
6,519.70
6,537.00
EPS (Diluted)
4.88
1.92
2.16
2.28
1.82
Diluted Shares Outstanding
6,458.30
6,467.00
6,536.60
6,519.70
6,537.00
EBITDA
31,365.00
12,418.00
14,157.00
14,899.00
11,881.00
Non-Operating Interest Income
106.00
47.00
57.00
107.00
38.00
About Pain Therapeutics
View Profile
